Gastroenterology
Volume 137, Issue 5 , Pages 1725-1735 , November 2009

Targeted Metabolomics Identifies Glucuronides of Dietary Phytoestrogens as a Major Class of MRP3 Substrates In Vivo

  • Koen van de Wetering

      Affiliations

    • Division of Molecular Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    • ,
  • Wouter Feddema

      Affiliations

    • Division of Molecular Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    • ,
  • J. Bernd Helms

      Affiliations

    • Department of Biochemistry and Cell Biology, Faculty of Veterinary Science, Utrecht University, The Netherlands
    • ,
  • Jos F. Brouwers

      Affiliations

    • Department of Biochemistry and Cell Biology, Faculty of Veterinary Science, Utrecht University, The Netherlands
    • ,
  • Piet Borst

      Affiliations

    • Division of Molecular Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    • Corresponding Author InformationCorrespondence Address correspondence to: Piet Borst, MD, Division of Molecular Biology (H8), Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. fax: (31) 20-669 1383

Received 3 April 2009 ,Accepted 25 June 2009.

References 

  1. Deeley RG, Westlake C, Cole SP. Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins. Physiol Rev. 2006;86:849–899
  2. Borst P, de Wolf C, van de Wetering K. Multidrug resistance-associated proteins 3, 4, and 5. Pflugers Arch. 2007;453:661–673
  3. Kruh GD, Belinsky MG, Gallo JM, et al. Physiological and pharmacological functions of Mrp2, Mrp3, and Mrp4 as determined from recent studies on gene-disrupted mice. Cancer Metastasis Rev. 2007;26:5–14
  4. Belinsky MG, Dawson PA, Shchaveleva I, et al. Analysis of the in vivo functions of Mrp3. Mol Pharmacol. 2005;68:160–168
  5. Zelcer N, van de Wetering K, de Waart R, et al. Mice lacking Mrp3 (Abcc3) have normal bile salt transport, but altered hepatic transport of endogenous glucuronides. J Hepatol. 2006;44:768–775
  6. Scheffer GL, Kool M, de Haas M, et al. Tissue distribution and induction of human multidrug resistant protein 3. Lab Invest. 2002;82:193–201
  7. Tukey RH, Strassburg CP. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol. 2000;40:581–616
  8. Manautou JE, de Waart DR, Kunne C, et al. Altered disposition of acetaminophen in mice with a disruption of the Mrp3 gene. Hepatology. 2005;42:1091–1098
  9. Zelcer N, van de Wetering K, Hillebrand M, et al. Mice lacking multidrug resistance protein 3 show altered morphine pharmacokinetics and morphine-6-glucuronide antinociception. Proc Natl Acad Sci U S A. 2005;120:7274–7279
  10. Qu J, Wang Y, Luo G, et al. Identification and determination of glucuronides and their aglycones in Erigeron breviscapus by liquid chromatography-tandem mass spectrometry. J Chromatogr A. 2001;928:155–162
  11. van de Wetering K, Zelcer N, Kuil A, et al. Multidrug resistance protein 2 and 3 provide alternative routes for hepatic excretion of morphine-glucuronides. Mol Pharmacol. 2007;72:387–394
  12. van de Wetering K, Burkon A, Feddema W, et al. Intestinal BCRP/Bcrp1 and MRP3/Mrp3 are involved in the pharmacokinetics of resveratrol. Mol Pharmacol. 2008;75:876–885
  13. Dixon RA. Phytoestrogens. Annu Rev Plant Biol. 2004;55:225–261
  14. D'Alessandro TL, Boersma-Maland BJ, Peterson TG, et al. Metabolism of phytoestrogen conjugates. Methods Enzymol. 2005;400:316–342
  15. Knust U, Hull WE, Spiegelhalder B, et al. Analysis of enterolignan glucuronides in serum and urine by HPLC-ESI-MS. Food Chem Toxicol. 2006;44:1038–1049
  16. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 2006;5:493–506
  17. Setchell KD, Gosselin SJ, Welsh MB, et al. Dietary estrogens—a probable cause of infertility and liver disease in captive cheetahs. Gastroenterology. 1987;93:225–233
  18. Adams NR. Permanent infertility in ewes exposed to plant oestrogens. Aust Vet J. 1990;67:197–201
  19. Whitten PL, Lewis C, Naftolin F. A phytoestrogen diet induces the premature anovulatory syndrome in lactationally exposed female rats. Biol Reprod. 1993;49:1117–1121
  20. Lewis RW, Brooks N, Milburn GM, et al. The effects of the phytoestrogen genistein on the postnatal development of the rat. Toxicol Sci. 2003;71:74–83
  21. Setchell KD, Brown NM, Desai P, et al. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J Nutr. 2001;131:S1362S–S1375S
  22. Akita H, Suzuki H, Hirohashi T, et al. Transport activity of human MRP3 expressed in Sf9 cells: comparative studies with rat MRP3. Pharm Res. 2002;19:34–41
  23. Zeng H, Liu G, Rea PA, et al. Transport of amphipathic anions by human multidrug resistance protein 3. Cancer Res. 2000;60:4779–4784
  24. Teng S, Piquette-Miller M. Hepatoprotective role of PXR activation and MRP3 in cholic acid-induced cholestasis. Br J Pharmacol. 2007;151:367–376
  25. Jacobs MN, Nolan GT, Hood SR. Lignans, bacteriocides and organochlorine compounds activate the human pregnane X receptor (PXR). Toxicol Appl Pharmacol. 2005;209:123–133
  26. Gregory PA, Lewinsky RH, Gardner-Stephen DA, et al. Regulation of UDP glucuronosyltransferases in the gastrointestinal tract. Toxicol Appl Pharmacol. 2004;199:354–363
  27. Chen J, Wang S, Jia X, et al. Disposition of flavonoids via recycling: comparison of intestinal versus hepatic disposition. Drug Metab Dispos. 2005;33:1777–1784
  28. Kuhnle G, Spencer JP, Chowrimootoo G, et al. Resveratrol is absorbed in the small intestine as resveratrol glucuronide. Biochem Biophys Res Commun. 2000;272:212–217
  29. Eeckhaut E, Struijs K, Possemiers S, et al. Metabolism of the lignan macromolecule into enterolignans in the gastrointestinal lumen as determined in the simulator of the human intestinal microbial ecosystem. J Agric Food Chem. 2008;56:4806–4812
  30. Maher JM, Slitt AL, Cherrington NJ, et al. Tissue distribution and hepatic and renal ontogeny of the multidrug resistance-associated protein (Mrp) family in mice. Drug Metab Dispos. 2005;33:947–955
  31. Jansen GH, Arts IC, Nielen MW, et al. Uptake and metabolism of enterolactone and enterodiol by human colon epithelial cells. Arch Biochem Biophys. 2005;435:74–82
  32. Axelson M, Setchell KD. The excretion of lignans in rats—evidence for an intestinal bacterial source for this new group of compounds. FEBS Lett. 1981;123:337–342
  33. Borst P, Zelcer N, van de Wetering K. MRP2 and 3 in health and disease. Cancer Lett. 2005;234:51–61

 Conflicts of interest The authors disclose no conflicts.

 Funding Supported by ZonMw for the experimental work in our laboratory (TOP grant number 40-00812-98-07-028, to K.vdW. and P.B.).

PII: S0016-5085(09)01137-8

doi: 10.1053/j.gastro.2009.06.052

Gastroenterology
Volume 137, Issue 5 , Pages 1725-1735 , November 2009

Article Tools

* Image Usage & Resolution